Aphria Commends UK Government on Medical Cannabis Legalization, Forms Alliance With Noted Neurologist and Leading Cannabis Advocate Professor Michael Barnes

This information was provided by prnewswire

Send your Press Release here.

The Company and Professor Barnes will collaborate on clinical trials to advance the applications of medical cannabis

LEAMINGTON, ON, Oct. 16, 2018 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APH and US OTC: APHQF) commends the Government of the United Kingdom for its decision last week to legalize medical cannabis. The Company is pleased to also announce that is has formed an alliance with noted UK-based neurologist and rehabilitation physician Professor Michael Barnes MD FRCP, a leading voice on medical cannabis policy in Europe.

 

“I applaud the UK government for taking this step to legalize medical cannabis,” said Vic Neufeld, Chief Executive Officer of Aphria. “It’s great news for patients in need across the UK and represents another major milestone in the advancement of medical cannabis around the world. We are also thrilled to join forces with Professor Barnes, among the world’s most respected and influential advocates for medical cannabis.”

Professor Barnes is a celebrated authority on neurological rehabilitation in the UK and internationally. He has a long-standing interest and expertise in the use of cannabinoids for the management of spasticity and in other neurological conditions. He was involved with the development of GW Pharma’s Sativex and provided the final expert independent opinion to the UK government prior to license approval. His review of cannabis medical indications for the all-party parliamentary group on drug reform was highly influential in the UK Government’s decision to legalize cannabis for medicinal purposes.

“This is a tremendous moment for medical cannabis in the UK and its momentum towards continued acceptance and application around the world,” said Professor Barnes. “I have long been interested in the medical applications of cannabis, and I look forward to a fruitful collaboration with Aphria, one of the leading global cannabis companies, to further the exploration of medical cannabis through clinical examination.”

Professor Barnes is an honorary professor of neurological rehabilitation at the University of Newcastle, Founder President of the World Federation of Neurological Rehabilitation and Past President of the British Society of Rehabilitation Medicine. He has also served as chief executive of NHS organizations.

Aphria and Professor Barnes are collaborating on clinical studies of patients in the UK and Canada to advance the understanding of the application of medical cannabis to certain conditions and disease states.

We Have A Good Thing Growing

Emerald contributor since March 2012

Comments

Your email address will not be published.